Search Results 2341-2350 of 16195 for Epilepsy (Partial Onset)
During the early phases (phases 1 and 2), researchers assess safety, side ... Illness of any duration and has laboratory-confirmed severe acute ...
The main objectives of this randomized trial comparing overminus lens treatment to non-overminus (spectacles without overminus or spectacles with plano lenses) ...
Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. The hippocampus is part of the brain that is important for memory. Avoiding the ...
The purpose of this study is to assess dose-related safety, early ... Onset of jaundice within prior 8 weeks 6. Maddrey's Discriminant Factor (mDF) ...
Patients with motion sickness, vertigo, or a seizure disorder will be excluded to prevent the theoretical risk of inducing or exacerbating symptoms related to ...
One Georgia family, however, has already experienced its benefits: genomic testing called whole exome sequencing helped Mayo Clinic neurologist Zbigniew Wszolek ...
In severe cases, individuals experience seizures or comas. ... Most importantly, the test allows distinction of NMOSD, ADEM, optic neuritis, and transverse ...
Stroke, Brain tumor, Traumatic brain injury, Movement disorder, Dementia, Epilepsy. Billie A. Schultz, M.D.. Physiatrist. Rochester, MN ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... Epilepsy. Show more areas of focus for Kai J. Miller, M.D., Ph.D. Anthony A. Stans, M.D.. Orthopedic Surgeon. Rochester, MN. Areas of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.